Nykredit A S Makes New $177.13 Million Investment in Gilead Sciences, Inc. $GILD
MarketBeat
Nykredit A/S has made a new investment of $177.13 million in Gilead Sciences, Inc., acquiring 1.4 million shares. This move increases institutional ownership in Gilead, which also reported strong quarterly revenue of $7.8 billion and a dividend of $0.82 per share. Analyst sentiment for GILD remains largely positive with a "Moderate Buy" consensus and a recent "Strong Buy" upgrade from Zacks.
Read the full story
This is a short summary. The complete article is published by MarketBeat.
Headline and summary aggregated from public news feeds. For information only — not financial advice.